Determining the significance of the N-MYC-WDR5 interaction in neuroblastoma.
确定 N-MYC-WDR5 相互作用在神经母细胞瘤中的重要性。
基本信息
- 批准号:10290439
- 负责人:
- 金额:$ 37.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgeAgreementAnchorage-Independent GrowthAreaAutomobile DrivingBindingBiologic CharacteristicBiological AssayBiologyBiomassCell LineCell ProliferationChemicalsChildChromatinClinicCollaborationsCombined Modality TherapyDNA SequenceDataDiagnosisDiseaseDistant MetastasisEventFamilyFamily memberFoundationsGap JunctionsGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGenomeGenomic approachGoalsHistologicHumanImpairmentInfantInterventionLinkLocationLymphomaMYC Family ProteinMYC geneMaintenanceMalignant Childhood NeoplasmMalignant NeoplasmsMeasuresModelingMusN-myc GeneNamesNeuroblastomaOncogenicOncoproteinsPrimary NeoplasmProtein BiosynthesisPublishingResearch ProposalsResolutionRouteSiteSolidSolid NeoplasmSurfaceSurvival RateTestingTherapeuticTractionTranscription ProcessTranslationsWorkangiogenesisbasec-myc Genescancer therapychromatin immunoprecipitationcombatdesigndisorder riskgene synthesisgenetic approachgenome-widehigh riskin vivomembermigrationmouse modelmutantneuroblastoma cellnew therapeutic targetnext generation sequencingprogramsrecruitrisk stratificationsmall moleculesmall molecule inhibitortranscription factortranscriptomicstumortumorigenesis
项目摘要
PROJECT SUMMARY/ABSTRACT
Neuroblastoma (NB) is the most common extracranial solid tumor found in infants, with almost all cases
being diagnosed by the age of five. The most severe cases of neuroblastoma are linked to amplification of
the N-MYC oncogene, which occurs in ~20% of all NB. N-MYC amplification is associated with ~50%
overall survival despite aggressive multimodal therapies, highlighting the need for new targeted therapies to
combat this pediatric cancer. N-MYC, like any MYC protein, must be able to recognize and bind chromatin
in order to activate its oncogenic potential. This project is built on the premise that an essential co-factor for
MYC proteins called WDR5 acts to recruit N-MYC to chromatin at genes that work to maintain
neuroblastoma function, and that targeting the N-MYC-WDR5 interaction can serve as a focal point for anti-
N-MYC based therapies. Support for this hypothesis comes from published data showing that WDR5 is a
conserved regulator of protein synthesis genes across multiple cellular contexts where WDR5 binds and
regulates these loci through its so-called “WIN”-site. In addition, the MYC family member, c-MYC, requires
WDR5 to bind genes associated with biomass accumulation and translation, and the c-MYC-WDR5
interaction is essential for tumor maintenance in lymphoma mouse models. In an N-MYC amplified NB cell
line, preliminary data reveal that targeting the WIN-site of WDR5 using small molecule inhibitors results in a
genome-wide decrease in WDR5 binding, with a subsequent loss of N-MYC binding at specific N-MYC-
WDR5 co-bound genes. And, importantly, disrupting the N-MYC-WDR5 interaction using genetic mutants
impairs the ability of N-MYC to drive anchorage-independent growth, providing evidence that there are
essential tumor functions tied to N-MYC that require interaction with WDR5. Together these data provide a
solid foundation for the notion that N-MYC requires WDR5 to bind and regulate N-MYC-WDR5 co-bound
genes that are important for driving N-MYC specific activities. The goal of this project is to interrogate the N-
MYC-WDR5 interaction in N-MYC amplified neuroblastoma cell lines and determine the influence that
WDR5 has on N-MYC driven transcriptional processes and neuroblastoma function using genetic and
chemical perturbations. Specific Aim 1 will employ genetic and genomic approaches to identify the genes
that are bound by N-MYC and WDR5, and determine at which genes the recruitment of N-MYC is
dependent on the N-MYC-WDR5 interaction. Specific Aim 2 will combine high-resolution transcriptomic
analyses with cellular and in vivo functional assays to challenge the significance of the N-MYC-WDR5
interaction. At the completion of these studies we will have identified the precise genes in which N-MYC
binding and transcription is regulated by the N-MYC-WDR5 interaction, and have directly challenged the
significance of the N-MYC-WDR5 interactions on multiple facets of NB tumorigenesis.
项目总结/摘要
神经母细胞瘤(NB)是最常见的颅外实体瘤发现婴儿,几乎所有的情况下,
在五岁的时候被诊断出来。最严重的神经母细胞瘤病例与
N-MYC癌基因,在所有NB中约占20%。N-MYC扩增与~50%
尽管有积极的多模式治疗,但总生存率仍然很高,这突出了对新靶向治疗的需求,
对抗这种儿科癌症。与任何MYC蛋白一样,N-MYC必须能够识别并结合染色质
以激活其致癌潜力。这个项目是建立在一个前提下,一个重要的辅助因素,
被称为WDR 5的MYC蛋白可以将N-MYC募集到染色质中的基因上,
神经母细胞瘤功能,靶向N-MYC-WDR 5相互作用可以作为抗神经母细胞瘤的焦点。
基于N-MYC的治疗。已发表的数据支持了这一假设,表明WDR 5是一种
在WDR 5结合的多种细胞环境中的蛋白质合成基因的保守调节因子,
通过其所谓的“WIN”位点调节这些位点。此外,MYC家族成员c-MYC需要
WDR 5结合与生物量积累和翻译相关的基因,以及c-MYC-WDR 5结合与生物量积累和翻译相关的基因。
相互作用对于淋巴瘤小鼠模型中的肿瘤维持至关重要。在N-MYC扩增的NB细胞中
线,初步数据显示,靶向WDR 5的WIN-site使用小分子抑制剂,导致
WDR 5结合的全基因组减少,随后在特异性N-MYC-
WDR 5共结合基因。而且,重要的是,使用遗传突变体破坏N-MYC-WDR 5相互作用,
削弱N-MYC驱动锚定独立生长的能力,提供证据表明,
与N-MYC相关的重要肿瘤功能需要与WDR 5相互作用。这些数据提供了一个
N-MYC需要WDR 5来结合和调节N-MYC-WDR 5共结合的概念的坚实基础
这些基因对于驱动N-MYC特异性活性很重要。这个项目的目标是询问N-
在N-MYC扩增的神经母细胞瘤细胞系中MYC-WDR 5相互作用,并确定
WDR 5具有N-MYC驱动的转录过程和神经母细胞瘤功能,
化学扰动。具体目标1将采用遗传学和基因组学方法来确定基因
与N-MYC和WDR 5结合,并确定N-MYC的募集是在哪些基因上进行的。
依赖于N-MYC-WDR 5相互作用。Specific Aim 2将联合收割机高分辨率转录组学
用细胞和体内功能测定进行分析,以挑战N-MYC-WDR 5的意义
互动在这些研究完成后,我们将确定N-MYC在其中的精确基因。
结合和转录受N-MYC-WDR 5相互作用的调节,并直接挑战了
N-MYC-WDR 5相互作用在NB肿瘤发生的多个方面的意义。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think.
- DOI:10.3390/jcm13010274
- 发表时间:2024-01-03
- 期刊:
- 影响因子:3.9
- 作者:Weissmiller, April M.;Fesik, Stephen W.;Tansey, William P.
- 通讯作者:Tansey, William P.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
April M. Weissmiller其他文献
MYC regulates ribosome biogenesis and mitochondrial gene expression programs through interaction with Host Cell Factor-1
MYC 通过与宿主细胞因子 1 相互作用调节核糖体生物合成和线粒体基因表达程序
- DOI:
10.1101/2020.06.22.164764 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Tessa M. Popay;Jing Wang;Clare M. Adams;S. Codreanu;S. Sherrod;J. McClean;L. R. Thomas;S. Lorey;Y. Machida;April M. Weissmiller;C. M. Eischen;Qi Liu;W. Tansey - 通讯作者:
W. Tansey
April M. Weissmiller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('April M. Weissmiller', 18)}}的其他基金
Exposing the role of MYC in small cell carcinoma of the ovary hypercalcemic type
揭示 MYC 在卵巢高钙血症型小细胞癌中的作用
- 批准号:
10728702 - 财政年份:2023
- 资助金额:
$ 37.98万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Directed Grant